Long-Term Outcomes of Rheohaemapheresis in the Treatment of Dry Form of Age-Related Macular Degeneration

Table 4

Indicators of rheological effectivity.

Followed parameter	Mean	SD	Mean	SD	% of difference	𝑃
Immunoglobulin M (g/L)	0,85	0,59	0,30	0,35	−64,50	<0,001
𝛼2-macroglobulin (mg/dL)	136,19	56,18	56,99	35,36	−58,16	<0,001
Total cholesterol (mmol/L)	4,33	1,25	1,76	0,49	−59,28	<0,001
LDL cholesterol (mmol/L)	2,45	1,02	0,74	0,37	−69,85	<0,001
Lipoprotein (a) (g/L)	0,23	0,31	0,10	0,19	−58,92	<0,001
Apolipoprotein B (g/L)	0,71	0,26	0,20	0,15	−72,09	<0,001
Fibrinogen (g/L)	2,96	0,68	1,02	0,29	−65,68	<0,001
Blood viscosity (mPa⋅s)	6,24	1,29	5,31	0,92	−14,89	<0,001
Plasma viscosity (mPa⋅s)	2,06	0,35	1,81	0,42	−11,96	<0,001

SD: standard deviation.
LDL: low-density lipoprotein.